WHO ICTRP trial
Mechanism of MIP immunotherapy in multibacillary leprosy
CTRI/2023/12/060545 · Clinical Trials Registry India (CTRI) · Not Recruiting
Key facts
| Trial ID | CTRI/2023/12/060545 |
|---|---|
| Public title | Mechanism of MIP immunotherapy in multibacillary leprosy |
| Scientific title | Molecular Mechanisms of Immunomodulation Imparted by Mycobacterium indicus pranii (MIP) vaccine against multibacillary leprosy - M2I2MIP |
| Primary sponsor | Leprosy Research Initiative (LRI), Netherlands |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase 4 |
| Countries | India |
| Conditions | Health Condition 1: A304- Borderline lepromatous leprosy Health Condition 2: A303- Borderline leprosy Health Condition 3: A302- Borderline tuberculoid leprosy Health Condition 4: A305- Lepromatous leprosy Health Condition 5: A301… |
| Interventions | Intervention1: Mycobacterium Indicus Pranii (MIP) vaccine and standard WHO multibacillary multidrug therapy (MBMDT): 0.1 ml of Mycobacterium Indicus Pranii (MIP) will be injected intra-dermal in the deltoid area at the start of therapy and… |
| Registration date | Dec 19, 2023 |
| Target size | 236 |
| Secondary IDs | NIL |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: